Paper · 54578
Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
Jennings G and 5 others. Lancet, 1976. Cited by 120 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Papers, record 54578. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/54578
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arrhythmias, Cardiac | Major topic |
| Disopyramide | Major topic |
| Myocardial Infarction | Major topic |
| Pyridines | Major topic |
| Administration, Oral | |
| Atrial Fibrillation | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Heart Block | |
| Humans | |
| Placebos | |
| Ventricular Fibrillation |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,216,514 | The influence of pH on the buccal absorption and renal excretion of disopyramide in man. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/22216514 | PubMed |
| 6,840,167 | Plasma concentration of disopyramide given as capsules and controlled release tablets. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6840167 | PubMed |
| 6,832,199 | Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6832199 | PubMed |
| 6,800,757 | New antiarrhythmic drugs: their place in therapy. | Drugs | 1981 | https://conductscience.org/library/papers/6800757 | PubMed |
| 6,753,888 | Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6753888 | PubMed |
| 6,753,887 | A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6753887 | PubMed |
| 6,439,233 | Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6439233 | PubMed |
| 6,380,549 | Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine. | Br Heart J | 1984 | https://conductscience.org/library/papers/6380549 | PubMed |
| 6,369,290 | Oral disopyramide after admission to hospital with suspected acute myocardial infarction. U. K. Rythmodan Multicentre Study Group. | Postgrad Med J | 1984 | https://conductscience.org/library/papers/6369290 | PubMed |
| 3,304,965 | Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias. | Drugs | 1987 | https://conductscience.org/library/papers/3304965 | PubMed |
1 to 10 of 22
See all 22 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/54578
GET https://conductscience.org/api/papers/v1/54578/cited_by?page=2